Indicated for hypertension to manage cardiovascular load and support blood pressure reduction.
Mechanism of Action
Nebivolol is a unique beta-1 blocker that also induces nitric oxide-mediated vasodilation. This dual action reduces systemic vascular resistance while lowering heart rate and myocardial contractility.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
24 hours
Contraindications
Severe bradycardia, Second or third degree heart block, Sick sinus syndrome, Severe hepatic impairment, Cardiogenic shock
Severe Adverse Events
Bronchospasm, Heart failure exacerbation, Severe bradycardia — requires immediate medical attention
Information related to Bystolic is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
